Reassessment of Dobutamine, Dopamine, and Milrinone in the Management of Acute Heart Failure Syndromes

This publication has 69 references indexed in Scilit:

• Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
  American Heart Journal, 2005
• Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design
  American Heart Journal, 2004
• Inotropes in the beta-blocker era
  Clinical Cardiology, 2000
• Effects of pulsed β-stimulant therapy on β-adrenoceptors and chronotropic responsiveness in chronic heart failure
  The Lancet, 1995
• New Positive Inotropic Agents in the Treatment of Congestive Heart Failure
  New England Journal of Medicine, 1986
• Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure
  The American Journal of Cardiology, 1985
• Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
  Circulation, 1984
• Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.
  Circulation, 1984
• Drug-induced conditioning in congestive heart failure.
  Circulation, 1982
• A New Inotropic Drug: Its Promise and a Caution
  New England Journal of Medicine, 1978